<VariationArchive VariationID="518424" VariationName="NM_000478.6(ALPL):c.18del (p.Val7fs)" VariationType="Deletion" Accession="VCV000518424" Version="5" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-06-17" DateCreated="2018-09-14" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="508966" VariationID="518424">
      <GeneList>
        <Gene Symbol="ALPL" FullName="alkaline phosphatase, biomineralization associated" GeneID="249" HGNC_ID="HGNC:438" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p36.12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="21508984" stop="21578410" display_start="21508984" display_stop="21578410" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="21835857" stop="21904904" display_start="21835857" display_stop="21904904" Strand="+" />
          </Location>
          <OMIM>171760</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000478.6(ALPL):c.18del (p.Val7fs)</Name>
      <CanonicalSPDI>NC_000001.11:21554098:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1p36.12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="21554099" stop="21554099" display_start="21554099" display_stop="21554099" variantLength="1" positionVCF="21554098" referenceAlleleVCF="TA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="21880592" stop="21880592" display_start="21880592" display_stop="21880592" variantLength="1" positionVCF="21880591" referenceAlleleVCF="TA" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>V7fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.21880592del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.21880592del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.21554099del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.21554099del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008940.1" sequenceAccession="NG_008940" sequenceVersion="1" change="g.49735del">
            <Expression>NG_008940.1:g.49735del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000478.6" sequenceAccession="NM_000478" sequenceVersion="6" change="c.18del" MANESelect="true">
            <Expression>NM_000478.6:c.18del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000469.3" sequenceAccession="NP_000469" sequenceVersion="3" change="p.Val7fs">
            <Expression>NP_000469.3:p.Val7fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369803.2" sequenceAccession="NM_001369803" sequenceVersion="2" change="c.18del">
            <Expression>NM_001369803.2:c.18del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356732.1" sequenceAccession="NP_001356732" sequenceVersion="1" change="p.Val7fs">
            <Expression>NP_001356732.1:p.Val7fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369804.2" sequenceAccession="NM_001369804" sequenceVersion="2" change="c.18del">
            <Expression>NM_001369804.2:c.18del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356733.1" sequenceAccession="NP_001356733" sequenceVersion="1" change="p.Val7fs">
            <Expression>NP_001356733.1:p.Val7fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369805.2" sequenceAccession="NM_001369805" sequenceVersion="2" change="c.18del">
            <Expression>NM_001369805.2:c.18del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356734.1" sequenceAccession="NP_001356734" sequenceVersion="1" change="p.Val7fs">
            <Expression>NP_001356734.1:p.Val7fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127501.4" sequenceAccession="NM_001127501" sequenceVersion="4" change="c.-104-6527del">
            <Expression>NM_001127501.4:c.-104-6527del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001177520.3" sequenceAccession="NM_001177520" sequenceVersion="3" change="c.-54-6527del">
            <Expression>NM_001177520.3:c.-54-6527del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1558543066" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000478.6(ALPL):c.18del (p.Val7fs) AND Infantile hypophosphatasia" Accession="RCV000678683" Version="2">
        <ClassifiedConditionList TraitSetID="3766">
          <ClassifiedCondition DB="MedGen" ID="C0268412">Infantile hypophosphatasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2018-02-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000478.6(ALPL):c.18del (p.Val7fs) AND Hypophosphatasia" Accession="RCV001731812" Version="1">
        <ClassifiedConditionList TraitSetID="8894">
          <ClassifiedCondition DB="MedGen" ID="C0020630">Hypophosphatasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-09-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000478.6(ALPL):c.18del (p.Val7fs) AND Adult hypophosphatasia" Accession="RCV003465354" Version="2">
        <ClassifiedConditionList TraitSetID="3768">
          <ClassifiedCondition DB="MedGen" ID="C0268413">Adult hypophosphatasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-02-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-29" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2018-09-14" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22913777</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33240318</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8894" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="14484" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hypophosphatasia</ElementValue>
                <XRef ID="23875" DB="GeneTests" />
                <XRef ID="Hypophosphatasia/3677" DB="Genetic Alliance" />
                <XRef ID="MONDO:0018570" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Phosphoethanol-aminuria</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6734" />
                <XRef ID="6734" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Hypophosphatasia is characterized by defective mineralization of growing or remodeling bone, with or without root-intact tooth loss, in the presence of low activity of serum and bone alkaline phosphatase. Clinical features range from stillbirth without mineralized bone at the severe end to pathologic fractures of the lower extremities in later adulthood at the mild end. While the disease spectrum is a continuum, seven clinical forms of hypophosphatasia are usually recognized based on age at diagnosis and severity of features: Perinatal (severe): characterized by pulmonary insufficiency and hypercalcemia. Perinatal (benign): prenatal skeletal manifestations that slowly resolve into one of the milder forms. Infantile: onset between birth and age six months of clinical features of rickets without elevated serum alkaline phosphatase activity. Severe childhood (juvenile): variable presenting features progressing to rickets. Mild childhood: low bone mineral density for age, increased risk of fracture, and premature loss of primary teeth with intact roots. Adult: characterized by stress fractures and pseudofractures of the lower extremities in middle age, sometimes associated with early loss of adult dentition. Odontohypophosphatasia: characterized by premature exfoliation of primary teeth and/or severe dental caries without skeletal manifestations.</Attribute>
                <XRef ID="NBK1150" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301329</ID>
                <ID Source="BookShelf">NBK1150</ID>
              </Citation>
              <XRef ID="436" DB="Orphanet" />
              <XRef ID="C0020630" DB="MedGen" />
              <XRef ID="MONDO:0018570" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3766" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="2390" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Infantile hypophosphatasia</ElementValue>
                <XRef ID="Infantile+hypophosphatasia/8660" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009427" DB="MONDO" />
                <XRef ID="55236002" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HOPS</ElementValue>
                <XRef Type="MIM" ID="241500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hypophosphatasia is characterized by defective mineralization of growing or remodeling bone, with or without root-intact tooth loss, in the presence of low activity of serum and bone alkaline phosphatase. Clinical features range from stillbirth without mineralized bone at the severe end to pathologic fractures of the lower extremities in later adulthood at the mild end. While the disease spectrum is a continuum, seven clinical forms of hypophosphatasia are usually recognized based on age at diagnosis and severity of features: Perinatal (severe): characterized by pulmonary insufficiency and hypercalcemia. Perinatal (benign): prenatal skeletal manifestations that slowly resolve into one of the milder forms. Infantile: onset between birth and age six months of clinical features of rickets without elevated serum alkaline phosphatase activity. Severe childhood (juvenile): variable presenting features progressing to rickets. Mild childhood: low bone mineral density for age, increased risk of fracture, and premature loss of primary teeth with intact roots. Adult: characterized by stress fractures and pseudofractures of the lower extremities in middle age, sometimes associated with early loss of adult dentition. Odontohypophosphatasia: characterized by premature exfoliation of primary teeth and/or severe dental caries without skeletal manifestations.</Attribute>
                <XRef ID="NBK1150" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301329</ID>
                <ID Source="BookShelf">NBK1150</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="pmc">3061990</ID>
              </Citation>
              <XRef ID="247651" DB="Orphanet" />
              <XRef ID="436" DB="Orphanet" />
              <XRef ID="C0268412" DB="MedGen" />
              <XRef Type="MIM" ID="241500" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3768" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2275" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Adult hypophosphatasia</ElementValue>
                <XRef ID="Adult+hypophosphatasia/7639" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007798" DB="MONDO" />
                <XRef ID="20756002" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Hypophosphatasia is characterized by defective mineralization of growing or remodeling bone, with or without root-intact tooth loss, in the presence of low activity of serum and bone alkaline phosphatase. Clinical features range from stillbirth without mineralized bone at the severe end to pathologic fractures of the lower extremities in later adulthood at the mild end. While the disease spectrum is a continuum, seven clinical forms of hypophosphatasia are usually recognized based on age at diagnosis and severity of features: Perinatal (severe): characterized by pulmonary insufficiency and hypercalcemia. Perinatal (benign): prenatal skeletal manifestations that slowly resolve into one of the milder forms. Infantile: onset between birth and age six months of clinical features of rickets without elevated serum alkaline phosphatase activity. Severe childhood (juvenile): variable presenting features progressing to rickets. Mild childhood: low bone mineral density for age, increased risk of fracture, and premature loss of primary teeth with intact roots. Adult: characterized by stress fractures and pseudofractures of the lower extremities in middle age, sometimes associated with early loss of adult dentition. Odontohypophosphatasia: characterized by premature exfoliation of primary teeth and/or severe dental caries without skeletal manifestations.</Attribute>
                <XRef ID="NBK1150" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301329</ID>
                <ID Source="BookShelf">NBK1150</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="pmc">3061990</ID>
              </Citation>
              <XRef ID="247676" DB="Orphanet" />
              <XRef ID="436" DB="Orphanet" />
              <XRef ID="C0268413" DB="MedGen" />
              <XRef Type="MIM" ID="146300" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1415967" SubmissionDate="2018-04-03" DateLastUpdated="2018-09-14" DateCreated="2018-09-14">
        <ClinVarSubmissionID localKey="SUB3774578" submittedAssembly="GRCh37" title="SUB3774578" />
        <ClinVarAccession Accession="SCV000693855" DateUpdated="2018-09-14" DateCreated="2018-09-14" Type="SCV" Version="1" SubmitterName="Children's Hospital of Soochow University, Soochow University" OrgID="506444" OrganizationCategory="clinic" OrgAbbreviation="CHCU" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-02-26">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALPL">
              <Name>alkaline phosphatase, liver/bone/kidney</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000478.4:exon 2</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000478.4:c.18delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="241500" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB3774578</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3877428" SubmissionDate="2021-10-22" DateLastUpdated="2021-10-30" DateCreated="2021-10-30">
        <ClinVarSubmissionID localKey="NM_000478.5:c.18delA|MedGen:C0020630" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001983479" DateUpdated="2021-10-30" DateCreated="2021-10-30" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-09-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22913777</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33240318</ID>
          </Citation>
          <Comment>Variant summary: ALPL c.18delA (p.Val7TyrfsX12) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 251486 control chromosomes. c.18delA has been reported in the literature as a compound heterozygous genotype in at-least two individuals affected with Hypophosphatasia (example, Cui_2012, Zhu_2020). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALPL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000478.5:c.18delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0020630" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10541510</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7845522" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000478.6:c.18del|OMIM:146300" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004192583" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000478.6:c.18del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="146300" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1415967" TraitType="Disease" MappingType="XRef" MappingValue="241500" MappingRef="OMIM">
        <MedGen CUI="C0268412" Name="Infantile hypophosphatasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3877428" TraitType="Disease" MappingType="XRef" MappingValue="C0020630" MappingRef="MedGen">
        <MedGen CUI="C0020630" Name="Hypophosphatasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7845522" TraitType="Disease" MappingType="XRef" MappingValue="146300" MappingRef="OMIM">
        <MedGen CUI="C0268413" Name="Adult hypophosphatasia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

